Provost Miriam 4
4 · TransMedics Group, Inc. · Filed Feb 22, 2023
Insider Transaction Report
Form 4
Provost Miriam
VP of US Regulatory & FDA Rel.
Transactions
- Award
Stock Option (Right to Buy)
2023-02-20+8,705→ 8,705 totalExercise: $66.10Exp: 2033-02-20→ Common Stock (8,705 underlying) - Award
Common Stock
2023-02-20+5,685→ 20,839 total
Footnotes (2)
- [F1]Includes 5,685 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027, subject to continued service.